CPS-077 - The impact of annual price revision based on external reference pricing on medicines between 2012 and 2023, in Portugal

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: CPS-077
• By: TEIXEIRA RODRIGUES, António (Life and Health Sciences Research Institute [ICVS], School of Medicine, University of Minho, Portugal)
• Co-author(s): Mr José Pedro Guerreiro (Centre for Health Evaluation & Research/Infosaúde, National Association of Pharmacies (CEFAR/IF, ANF), Lisbon, Portugal)
  Mrs Inês Teixeira (Portuguese Pharmaceutical Industry Association (APIFARMA), Lisbon, Portugal)
  Mrs Klára Dimitrovová (Centre for Health Evaluation & Research/Infosaúde, National Association of Pharmacies (CEFAR/IF, ANF), Lisbon, Portugal / Comprehensive Health Research Center, CHRC, NOVA University Lisbon, Lisbon, Portugal)
  Mr Frederico Silva Leal (Portuguese Pharmaceutical Industry Association (APIFARMA), Lisbon, Portugal / ISCAL – Lisbon Accounting and Business School, Polytechnic University of Lisbon, Lisbon, Portugal)
  Mr António Teixeira Rodrigues (Centre for Health Evaluation & Research/Infosaúde, National Association of Pharmacies (CEFAR/IF, ANF), Lisbon, Portugal / Life and Health Sciences Research Institute [ICVS], School of Medicine, University of Minho, Braga, Portugal / ICVS/3B’s-PT Government Associate Laboratory, Braga/Guimarães, Portugal)
  Mr José Zorro Mendes (ISEG - Lisbon School of Economics & Management, Lisbon, Portugal)
  
• Abstract:

  Introduction: External Reference Pricing (ERP) is a widely used price control mechanism to inform decisions on pricing and coverage of pharmaceutical products. This approach involves referencing prices from one or several countries to establish a benchmark or reference price for the purpose of setting or negotiating the price of the medicine in a..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login